Home/Filings/4/0001725160-22-000068
4//SEC Filing

SUN ANTHONY Y 4

Accession 0001725160-22-000068

CIK 0001725160other

Filed

Apr 4, 8:00 PM ET

Accepted

Apr 5, 6:52 PM ET

Size

12.5 KB

Accession

0001725160-22-000068

Insider Transaction Report

Form 4
Period: 2022-04-04
SUN ANTHONY Y
DirectorPresident & CEO
Transactions
  • Sale

    Common Stock

    2022-04-04$48.50/sh10,471$507,8441,186,060 total
  • Sale

    Common Stock

    2022-04-05$51.34/sh7,971$409,2011,178,089 total
  • Sale

    Common Stock

    2022-04-05$52.11/sh2,500$130,2731,175,589 total
Holdings
  • Common Stock

    (indirect: By Spouse)
    103,650
  • Common Stock

    (indirect: By LLC)
    974,302
  • Common Stock

    (indirect: By Trust)
    213,600
  • Common Stock

    (indirect: By Trust)
    125,000
Footnotes (5)
  • [F1]The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 21, 2021.
  • [F2]The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $50.84 to $51.83. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F3]The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $51.85 to $52.70. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F4]Represents shares nominally held by Hao Bao Zi Trust LLC on behalf of the Hao Bao Zi Trust (the "Trust"), the sole member of Hao Bao Zi Trust LLC. The Reporting Person's spouse is the investment adviser with sole power to make investment decisions regarding the securities held by the Trust. The Reporting Person disclaims beneficial ownership of the securities held by Hao Bao Zi Trust LLC except to the extent of his pecuniary interest therein, if any.
  • [F5]Represents shares nominally held by Hao Jiao Zi Trust LLC on behalf of the Hao Jiao Zi Trust (the "Trust"), the sole member of Hao Jiao Zi Trust LLC. The Reporting Person's spouse is the investment adviser with sole power to make investment decisions regarding the securities held by the Trust. The Reporting Person disclaims beneficial ownership of the securities held by Hao Jiao Zi Trust LLC except to the extent of his pecuniary interest therein, if any.

Issuer

Zentalis Pharmaceuticals, Inc.

CIK 0001725160

Entity typeother

Related Parties

1
  • filerCIK 0001377952

Filing Metadata

Form type
4
Filed
Apr 4, 8:00 PM ET
Accepted
Apr 5, 6:52 PM ET
Size
12.5 KB